3 Pharmacokinetics of heparin and low molecular weight heparin
- 1 July 1990
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 3 (3) , 531-544
- https://doi.org/10.1016/s0950-3536(05)80017-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Heparin degradation in the endothelial cellsThrombosis Research, 1987
- The disappearance of a low molecular weight heparin fraction (cy 216) differs from standard heparin in rabbitsThrombosis Research, 1987
- Heparin half‐life and sensitivity in normal subjects and in patients affected by deep vein thrombosisEuropean Journal of Clinical Investigation, 1986
- Endothelial binding sites for heparin. Specificity and role in heparin neutralizationBiochemical Journal, 1986
- Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationThrombosis Research, 1985
- Binding and endocytosis of heparin by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Prediction of Heparin Requirements in Acute Thromboplastic Venous DiseaseArchives of Surgery, 1985
- Subcutaneous administration of heparin a randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosisThrombosis Research, 1982
- An objective study of alternative methods of heparin administrationThrombosis Research, 1980
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976